Developing evolution-resistant drugs for COVID-19.

Published in: eLife (2022)

Analyzing how mutations affect the main protease of SARS-CoV-2 may help researchers develop drugs that are effective against current and future variants of the virus.

Keyphrases

sars cov
respiratory syndrome coronavirus
coronavirus disease
copy number
current status
drug induced
dna methylation